Use of Biologic Treatment for Cutaneous Behcet's Disease: An Evidence-Based Review

Dana Taghaddos; Victoria Young; Siddhartha Sood; Ahmed Bagit; Khalad Maliyar; Muskaan Sachdeva; Asfandyar Mufti; Jensen Yeung

doi:10.1177/12034754241303100

Use of Biologic Treatment for Cutaneous Behcet's Disease: An Evidence-Based Review

J Cutan Med Surg. 2024 Dec 3:12034754241303100. doi: 10.1177/12034754241303100. Online ahead of print.

Authors

Dana Taghaddos¹, Victoria Young², Siddhartha Sood², Ahmed Bagit², Khalad Maliyar³, Muskaan Sachdeva³, Asfandyar Mufti^{3

4}, Jensen Yeung^{3

4

5

6}

Affiliations

¹ Faculty of Medicine, McMaster University, Hamilton, ON, Canada.
² Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
³ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
⁴ Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
⁵ Division of Dermatology, Women's College Hospital, Toronto, ON, Canada.
⁶ Probity Medical Research, Waterloo, ON, Canada.

PMID: 39628059
DOI: 10.1177/12034754241303100

No abstract available

Keywords: Behcet’s disease; adalimumab; biologic agents; biologic treatment; mucocutaneous lesions; systematic review; treatment outcomes; ustekinumab.

Publication types

Letter